SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU CRYPTO is trending due to its exceptionally active and dedicated community, which is relentlessly building a permissionless brand with tangible real-world products like Kendu Energy and Kendu Spice. The community emphasizes KENDU's growing IRL presence and decentralized business initiatives across multiple chains, fostering strong conviction in its long-term potential. Despite broader market conditions, sentiment remains overwhelmingly bullish, viewing KENDU as a resilient and unavoidable force poised for significant growth.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is actively trending as community sentiment appears divided, with many anticipating a significant rally and 'altseason' following the conclusion of recent tax loss selling, hoping for substantial price increases. Conversely, a vocal group views current movements as temporary and predicts further declines, dismissing its long-term potential as a 'shitcoin' while both sides debate its future trajectory.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

Pepe is trending amidst strong community speculation, with many users anticipating a significant upward movement, including hopes of 'dropping a zero' in its price, and a potential 'Alt season' incoming. The community is actively discussing its 'no transaction taxes' mechanic, contributing to an optimistic trading environment, though some express skepticism about its long-term viability.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending due to its recent announcement of record-high December and Q4 vehicle deliveries for 2025, pushing cumulative sales close to one million units. The community is largely optimistic, highlighting the strong year-over-year growth and the potential for profitability, yet a vocal contingent points to perceived market manipulation as the reason the stock's valuation has not adequately reflected this performance. This fuels debate over its position within the competitive Chinese EV market and expectations for a significant re-rating.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is a trending topic with a polarized community, as supporters emphasize its Japan FSA compliance, ongoing IoT utility development, a completed token supply dilution phase, and anticipation of major news in 2026. Conversely, critics frequently label the project a scam, citing continuous price depreciation and perceived lack of tangible progress.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

Chainlink is trending amidst strong institutional interest, fueled by the launch of a Grayscale spot ETF and continued whale accumulation anticipating real-world asset adoption and expanding CCIP utility across banks. The community is actively discussing LINK's fundamental role as essential cross-chain infrastructure and its fixed supply, viewing current price levels as a potential accumulation opportunity for future growth.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is actively discussed due to its strategic expansion in the anticoagulation therapy space, highlighted by recent pipeline acquisitions and manufacturing progress for its lead candidate, tecarfarin. Community sentiment focuses on the potential impact of tecarfarin's regulatory designations and a key collaboration for its pivotal trial. However, ongoing concerns about potential dilution and the stock's low float contribute to a volatile trading dynamic.

Alchemy Investments Acquisition Corp. 1 is a blank check company, which engages in merger, share exchange, asset acquisition, share purchase, and reorganization or similar business combination. The company was founded on October 27, 2021 and is headquartered in Newark, DE.

Alchemy Investments Acquisition Corp 1 - Ordinary Shares - Class A

Alchemy Investments Acquisition Corp 1 (ALCY) is trending as a low-float SPAC, currently experiencing a surge in trading volume and retail interest. The community is actively discussing its potential for a parabolic run, drawing comparisons to recent "shell company rippers" and fueling expectations of significant price appreciation. This momentum is part of a broader speculative trend in low-float SPACs, with traders anticipating continued upward movement.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health Inc. is a major talking point as the stock experiences persistent declines, fueled by end-of-year tax loss harvesting and a high short interest. Investor sentiment is sharply polarized, with bulls emphasizing the company's strong subscriber growth and strategic expansions into new health verticals and international markets as a buying opportunity. Conversely, bears highlight ongoing valuation concerns, intense competition in the GLP-1 weight loss drug market, and alleged market manipulation, despite recent company announcements like a new share buyback program and discussions around distributing Novo Nordisk's newly approved oral Wegovy pill.

Amplify ETF Trust - Amplify Junior Silver Miners ETF

Amplify Junior Silver Miners ETF

SILJ is trending as silver continues its explosive rally to new all-time highs, fueled by structural deficits, robust industrial demand, and macroeconomic concerns over currency debasement. While the ETF has notably lagged silver's "crypto-like" surge, the community is buzzing with anticipation for a significant catch-up rally, driven by historically undervalued ratios and recent institutional interest suggesting junior miners are primed for outperformance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Rapport Therapeutics, Inc. (NASDAQ:RAPP) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Shares of Rapport Therapeutics, Inc. (NASDAQ:RAPP - Get Free Report) have earned an average recommendation of "Moderate Buy" from the seven research firms that are currently covering the company...

Rapport Therapeutics, Inc. (NASDAQ:RAPP) Receives Average Recommendation of "Moderate Buy" from Analysts

Shares of Rapport Therapeutics, Inc. (NASDAQ:RAPP - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the seven ratings firms that are currently covering the firm...

Rapport Therapeutics (NASDAQ:RAPP) CEO Sells $172,890.12 in Stock

Rapport Therapeutics, Inc. (NASDAQ:RAPP - Get Free Report) CEO Abraham Ceesay sold 5,833 shares of the stock in a transaction dated Wednesday, December 17th. The stock was sold at an average price of...

David Bredt Sells 8,500 Shares of Rapport Therapeutics (NASDAQ:RAPP) Stock

Rapport Therapeutics, Inc. (NASDAQ:RAPP - Get Free Report) insider David Bredt sold 8,500 shares of Rapport Therapeutics stock in a transaction on Monday, December 15th. The shares were sold at an...

Rapport Therapeutics (NASDAQ:RAPP) Insider Sells $255,170.00 in Stock

Rapport Therapeutics, Inc. (NASDAQ:RAPP - Get Free Report) insider David Bredt sold 8,500 shares of the firm's stock in a transaction dated Monday, December 15th. The stock was sold at an average...

Wall Street Zen Upgrades Rapport Therapeutics (NASDAQ:RAPP) to Hold

Wall Street Zen raised shares of Rapport Therapeutics from a "sell" rating to a "hold" rating in a research report on Sunday...

Rapport Therapeutics (NASDAQ:RAPP) Trading Up 5.4% - Here's Why

Rapport Therapeutics (NASDAQ:RAPP) Stock Price Up 5.4% - Time to Buy...

FY2027 Earnings Forecast for RAPP Issued By HC Wainwright

Rapport Therapeutics, Inc. (NASDAQ:RAPP - Free Report) - Analysts at HC Wainwright boosted their FY2027 EPS estimates for Rapport Therapeutics in a note issued to investors on Tuesday, December 9th...

Rapport Therapeutics, Inc. (RAPP) Is Up 9.03% in One Week: What You Should Know 

Does Rapport Therapeutics, Inc. (RAPP) have what it takes to be a top stock pick for momentum investors? Let's find out.

Rapport Therapeutics (NASDAQ:RAPP) Earns Buy Rating from BTIG Research

BTIG Research reaffirmed a "buy" rating and set a $47.00 target price on shares of Rapport Therapeutics in a report on Monday...

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

RAPP
Rapport Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest RAPP News

RAPPRapport Therapeutics Inc